Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(421/week)
Manufacturing
(319/week)
Technology
(320/week)
Energy
(213/week)
Other Manufacturing
(264/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
OncoSec Medical Incorporated.
Aug 14, 2020
OncoSec Medical Incorporated Announces Proposed Public Offering of Common Stock
Jun 22, 2020
OncoSec Presents Two Late-Breaking Abstracts on TAVO-PLUS at the American Association for Cancer Research (AACR) Virtual Annual Meeting II
Jun 09, 2020
OncoSec Expands KEYNOTE-890 Trial into First-Line Metastatic Triple Negative Breast Cancer (mTNBC) with TAVO(TM) and KEYTRUDA® Plus Chemotherapy
Jun 04, 2020
OncoSec to Present at Virtual Summer Investor Summit
May 21, 2020
OncoSec to Present Two Late-Breaking Pre-Clinical Abstracts on TAVO-PLUS at the American Association for Cancer Research (AACR) Virtual Annual Meeting II
May 13, 2020
OncoSec's TAVO(TM) Receives ATMP Certification from European Medicines Agency to Support Marketing Authorization Application in Metastatic Melanoma
May 06, 2020
OncoSec's TAVO(TM) in Combination with KEYTRUDA® Demonstrated 41% Overall Response Rate and 36% Complete Response in a Late-Stage Metastatic Melanoma Study Featured in 'Clinical Cancer Research'
Apr 21, 2020
OncoSec Presents Pre-Clinical Data from Its Visceral Lesion Applicator (VLA) and APOLLO Feasibility Study Demonstrating TAVO(TM) Can Be Safely Delivered and Electroporated in Liver at the Online Society of Interventional Radiology Annual Meeting
Apr 06, 2020
OncoSec Collaborates with Providence Cancer Institute to Conduct First-in-Human Trial of OncoSec's CORVax12, an Investigational Vaccine to Prevent COVID-19, Combining an Enhanced "Spike" DNA Sequence and TAVO(TM)
Mar 17, 2020
OncoSec Announces Publication of Positive TAVO(TM) Monotherapy Results in Metastatic Melanoma Patients in Annals of Oncology
Feb 11, 2020
OncoSec Strengthens its Board of Directors with Three New Appointments
Feb 04, 2020
Clinical Cancer Research highlights OncoSec's Merkel Cell Carcinoma Clinical Study on the Cover of its February Issue
Feb 03, 2020
OncoSec's Visceral Lesion Applicator (VLA) Electroporation Device Demonstrates Targeted Entry and Deployment in Both Lung and Liver in Data Presented at the Society of Interventional Oncology Annual Meeting
Jan 27, 2020
Data from OncoSec's Visceral Lesion Applicator (VLA) to be Presented at the Society of Interventional Oncology Annual Meeting
Dec 16, 2019
OncoSec to Receive Approximately $885,000 Through New Jersey Technology Business Tax (NOL) Program
Dec 05, 2019
OncoSec to Present Interim Data from Ongoing KEYNOTE-890 Study of TAVO(TM) and KEYTRUDA® in Late-Stage Metastatic Triple Negative Breast Cancer at the 2019 San Antonio Breast Cancer Symposium
Nov 26, 2019
OncoSec to Present at the 31st Annual Piper Jaffray Healthcare Conference
Nov 12, 2019
OncoSec Presents Immunological Data Associated with Positive Tumor Response from TAVO(TM) KEYNOTE Studies Evaluating Patients with Advanced Solid Tumors at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting
Nov 05, 2019
OncoSec to Present TAVO(TM) Immune Biomarker Data Associated with Positive Clinical Response from Ongoing KEYNOTE Studies at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting
Sep 26, 2019
OncoSec to Present at the Cantor 2019 Global Healthcare Conference
Page 1
››
Latest News
Mar 29, 2024
Global Automotive Semiconductor Market Outlook & Forecast 2023-2028: A Highly Fragmented $135 Bn Market...
Mar 29, 2024
Zep® Launches Fume Free Air Fryer & Oven Cleaner for the Modern Kitchen; Now Available Throughout the...
Mar 29, 2024
UC Berkeley FHL Vive Center Teams Up with BeamNG
Mar 29, 2024
University of Phoenix Receives Arizona Veteran Supportive Campus Recertification
Mar 29, 2024
PCI Announces Expansion of Mail Presort Operations to the Midwest, Boosting National Presence, Regional...
Mar 29, 2024
New Report Shows Massachusetts Customers Could Have Saved Hundreds of Millions in 2024 Through Competitive...
Mar 29, 2024
Global Surface Materials for Transportation Market Report 2024-2033: Growing Demand for Customization,...
Mar 29, 2024
Impacts of Extreme Weather on Interior Design Examined in New Research
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events